60 Degrees (SXTP)
1.48
-0.05 (3.27%)
Latest Headlines
Form 8-K 60 DEGREES PHARMACEUTICA For: Jun 03
June 3, 2026 4:57 PM - SEC Filing
60 Degrees Pharmaceuticals enrolls first patient in tafenoquine babesiosis trial
May 26, 2026 8:03 AM - StreetInsider
60 Degrees Pharmaceuticals Announces Early Enrollment of First Seasonal Patient in Clinical Trial of Tafenoquine for Patients Hospitalized with Babesiosis
May 26, 2026 8:02 AM - Globe NewsWire
H.C. Wainwright Downgrades 60 Degrees Pharmaceuticals Inc (SXTP) to Neutral
May 20, 2026 12:19 PM - StreetInsider
Form 3 60 DEGREES PHARMACEUTICA For: May 13 Filed by: Francois Eric
May 19, 2026 6:14 PM - SEC Filing
Form 8-K 60 DEGREES PHARMACEUTICA For: May 13
May 18, 2026 4:33 PM - SEC Filing
Form SCHEDULE 13G/A 60 DEGREES PHARMACEUTICA Filed by: Knight Therapeutics Inc.
May 15, 2026 4:05 PM - SEC Filing
Form SCHEDULE 13G/A 60 DEGREES PHARMACEUTICA Filed by: CVI Investments, Inc.
May 15, 2026 12:22 PM - SEC Filing
60 Degrees Pharmaceuticals Announces First Quarter 2026 Results
May 15, 2026 8:42 AM - Globe NewsWire
Form 10-Q 60 DEGREES PHARMACEUTICA For: Mar 31
May 15, 2026 8:12 AM - SEC Filing
Form SCHEDULE 13G/A 60 DEGREES PHARMACEUTICA Filed by: INTRACOASTAL CAPITAL, LLC
May 13, 2026 4:31 PM - SEC Filing
RedChip's Biotech Investor Conference Replays Now Available
April 20, 2026 8:04 AM - StreetInsider
60 Degrees Pharma makes malaria drug available on telehealth platform
April 15, 2026 8:04 AM - StreetInsider
60 Degrees Pharma Announces ARAKODA (tafenoquine) for Malaria Prevention is Now Available on Runway Health Travel Website
April 15, 2026 8:02 AM - Globe NewsWire
Infrastructure Capital and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
April 2, 2026 9:00 AM - StreetInsider
RedChip Showcases Public Companies Driving Biotech Innovation at April 16 Virtual Investor Conference
April 2, 2026 8:46 AM - StreetInsider
60 Degrees Pharmaceuticals Announces 2025 Annual Results
March 31, 2026 7:01 AM - Globe NewsWire
Form 10-K 60 DEGREES PHARMACEUTICA For: Dec 31
March 30, 2026 5:32 PM - SEC Filing
Form 8-K 60 DEGREES PHARMACEUTICA For: Mar 20
March 20, 2026 4:15 PM - SEC Filing
60 Degrees Pharmaceuticals files FDA notification for dietary supplement
March 18, 2026 8:02 AM - StreetInsider
60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (NDIN) with FDA for Australian Chestnut Extract
March 18, 2026 8:01 AM - Globe NewsWire
Form 424B5 60 DEGREES PHARMACEUTICA
March 13, 2026 5:17 PM - SEC Filing
Form 8-K 60 DEGREES PHARMACEUTICA For: Mar 13
March 13, 2026 5:15 PM - SEC Filing
Form 8-K 60 DEGREES PHARMACEUTICA For: Mar 12
March 12, 2026 4:37 PM - SEC Filing
Form 424B5 60 DEGREES PHARMACEUTICA
March 11, 2026 5:25 PM - SEC Filing
60 Degrees Pharmaceuticals reports babesiosis cures in small trial
March 11, 2026 7:24 AM - StreetInsider
60 Degrees Pharmaceuticals Announces All Patients Cured of Babesiosis After Tafenoquine Treatment in Expanded Use Clinical Trial
March 11, 2026 7:24 AM - Globe NewsWire
Full Article List
